DONALDSON Co INC (DCI) stock
Close on Oct 30, 2026Market cap $9.62BP/E 21.5Yield 1.47%
Earnings
Donaldson's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.
Quarterly results
Revenue and earnings per share from each of Donaldson's earnings releases, newest first
| Quarter | Reported | Revenue | YoY | EPS | Adj. EPS | Source |
|---|---|---|---|---|---|---|
| Q1 FY2027ended Oct 31, 2026 | Dec 3, 2026Expected | – | – | – | – | – |
| Q4 FY2026ended Jul 31, 2026 | Aug 26, 2026after the close | $1.06B | +8.0% | $1.10 | – | Release |
| Q3 FY2026ended Apr 30, 2026 | Jun 2, 2026after the close | $995.10M | +5.9% | $1.00 | $1.06 | Release |
| Q2 FY2026ended Jan 31, 2026 | Feb 26, 2026after the close | $896.30M | +3.0% | $0.78 | $0.83 | Release |
| Q1 FY2026ended Oct 31, 2025 | Dec 4, 2025after the close | $935.40M | +3.9% | $0.97 | $0.94 | Release |
| Q4 FY2025ended Jul 31, 2025 | Aug 27, 2025after the close | $980.70M | +4.8% | $0.97 | $1.03 | Release |
| Q3 FY2025ended Apr 30, 2025 | Jun 3, 2025after the close | $940.10M | +1.3% | $0.48 | $0.99 | Release |
| Q2 FY2025ended Jan 31, 2025 | Feb 27, 2025after the close | $870.00M | -0.8% | $0.79 | $0.83 | Release |
| Q1 FY2025ended Oct 31, 2024 | Dec 3, 2024after the close | $900.10M | +6.4% | $0.81 | $0.83 | Release |
| Q4 FY2024ended Jul 31, 2024 | Aug 28, 2024after the close | $935.40M | +6.4% | $0.90 | $0.94 | Release |
| Q3 FY2024ended Apr 30, 2024 | Jun 4, 2024after the close | $927.90M | +6.0% | $0.92 | $0.92 | Release |
| Q2 FY2024ended Jan 31, 2024 | Feb 28, 2024after the close | $876.70M | +5.8% | $0.81 | $0.81 | Release |
| Q1 FY2024ended Oct 31, 2023 | Nov 29, 2023after the close | $846.30M | -0.1% | $0.75 | $0.75 | Release |
| Q4 FY2023ended Jul 31, 2023 | Aug 29, 2023after the close | $879.50M | -1.2% | $0.75 | $0.78 | Release |
| Q3 FY2023ended Apr 30, 2023 | May 31, 2023after the close | $875.70M | +2.6% | $0.76 | $0.76 | Release |
| Q2 FY2023ended Jan 31, 2023 | Mar 1, 2023after the close | $828.30M | +3.2% | $0.70 | $0.75 | Release |
| Q1 FY2023ended Oct 31, 2022 | Nov 30, 2022after the close | $847.30M | +11.4% | $0.70 | $0.75 | Release |
| Q4 FY2022ended Jul 31, 2022 | Aug 31, 2022after the close | $890.00M | – | $0.81 | $0.84 | Release |
| Q3 FY2022ended Apr 30, 2022 | Jun 1, 2022after the close | $853.20M | – | $0.67 | $0.67 | Release |
| Q2 FY2022ended Jan 31, 2022 | Mar 2, 2022after the close | $802.50M | – | $0.57 | $0.57 | Release |
| Q1 FY2022ended Oct 31, 2021 | Dec 1, 2021after the close | $760.90M | – | $0.61 | – | Release |
| Q4 FY2021ended Jul 31, 2021 | Sep 2, 2021after the close | – | – | – | – | Filing |
| Q3 FY2021ended Apr 30, 2021 | Jun 2, 2021after the close | – | – | – | – | Filing |
| Q2 FY2021ended Jan 31, 2021 | Feb 25, 2021before the open | – | – | – | – | Filing |
| Q1 FY2021ended Oct 31, 2020 | Dec 3, 2020before the open | – | – | – | – | Filing |
| Q4 FY2020ended Jul 31, 2020 | Sep 3, 2020before the open | – | – | – | – | Filing |
Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.
Current guidance
Donaldson's latest outlook for periods it has not reported yet, compared with what it said before
| Metric | Period | Guidance | Before | Change | Given |
|---|---|---|---|---|---|
| Total Company sales | FY2026 | +3% – +7% | – | New | Aug 27, 2024 |
| Total operating margin | FY2026 | 15.8% – 16.6% | – | New | Aug 27, 2024 |
| sales growth | FY2027 | +5.5% – +9.5% | – | New | Aug 25, 2026 |
| Operating margin | FY2027 | 16.6% – 17.2% | – | New | Aug 25, 2026 |
| EPS | FY2027 | $4.22 – $4.38 | – | New | Aug 25, 2026 |
| Capital expenditures | FY2027 | $70.00M – $90.00M | – | New | Aug 25, 2026 |
| free cash flow conversion | FY2027 | 95% – 105% | – | New | Aug 25, 2026 |
Guidance vs results
The last range Donaldson gave before each report, against the figure it then reported. Full years add up the four quarters.
| Period | Metric | Guidance | Actual | Result |
|---|---|---|---|---|
| FY2026 | EPS (GAAP) | $3.92 – $4.08 | $3.85Σ4Q | Below range |
| FY2026 | Revenue growth | +3.5% – +5.5% | +5.28%Σ4Q | Within range |
| FY2025 | Adjusted full-year EPS | $3.64 – $3.70 | $3.68Σ4Q | Within range |
| FY2025 | Revenue growth | +1% – +3% | +2.92%Σ4Q | Within range |
Guidance history
Every forecast Donaldson put in an earnings release, newest first
| Given | Metric | Period | Guidance | Change |
|---|---|---|---|---|
| Aug 25, 2026 | Capital expenditures | FY2027 | $70.00M – $90.00M | New |
| Aug 25, 2026 | EPS | FY2027 | $4.22 – $4.38 | New |
| Aug 25, 2026 | Operating margin | FY2027 | 16.6% – 17.2% | New |
| Aug 25, 2026 | free cash flow conversion | FY2027 | 95% – 105% | New |
| Aug 25, 2026 | sales growth | FY2027 | +5.5% – +9.5% | New |
| Jun 1, 2026 | Capital expenditures | FY2026 | $60.00M – $75.00M | Reaffirmed |
| Jun 1, 2026 | organic adjusted full-year EPS | FY2026 | $3.94 – $4.01 | Raised |
| Jun 1, 2026 | adjusted free cash flow conversion | FY2026 | 85% – 95% | New |
| Jun 1, 2026 | Adjusted 2026 operating margin | FY2026 | 15.8% – 16.2% | Lowered |
| Jun 1, 2026 | Full-year repurchases | FY2026 | 1.2% | Reaffirmed |
| Jun 1, 2026 | fiscal 2026 adjusted effective income tax rate | FY2026 | 22% – 24% | Lowered |
| Jun 1, 2026 | Organic sales | FY2026 | +3% – +5% | Raised |
| Jun 1, 2026 | Mobile sales | FY2026 | +3.5% – +5.5% | Raised |
| Jun 1, 2026 | Life Sciences sales | FY2026 | +9% – +11% | Raised |
| Feb 25, 2026 | Capital expenditures | FY2026 | $60.00M – $75.00M | Lowered |
| Feb 25, 2026 | Adjusted full-year EPS | FY2026 | $3.93 – $4.01 | Lowered |
| Feb 25, 2026 | Adjusted 2026 operating margin | FY2026 | 16% – 16.4% | Lowered |
| Feb 25, 2026 | full-year repurchases | FY2026 | 1.2% | Lowered |
| Feb 25, 2026 | adjusted effective income tax rate | FY2026 | 22% – 24% | Lowered |
| Feb 25, 2026 | adjusted free cash flow conversion | FY2026 | 85% – 95% | Raised |
| Feb 25, 2026 | Mobile sales | FY2026 | +2% – +6% | Raised |
| Feb 25, 2026 | Industrial sales | FY2026 | -1% – +3% | Lowered |
| Feb 25, 2026 | Life Sciences sales | FY2026 | +5% – +9% | Raised |
| Feb 25, 2026 | Interest expense | FY2026 | $26.00M | Raised |
| Feb 25, 2026 | other income | FY2026 | $17.00M – $19.00M | Lowered |
| Feb 25, 2026 | Sales | FY2026 | +1% – +5% | Reaffirmed |
| Dec 3, 2025 | Capital expenditures | FY2026 | $65.00M – $85.00M | Reaffirmed |
| Dec 3, 2025 | Adjusted full-year EPS | FY2026 | $3.95 – $4.11 | New |
| Dec 3, 2025 | Adjusted 2026 operating margin | FY2026 | 16.2% – 16.8% | New |
| Dec 3, 2025 | adjusted effective income tax rate | FY2026 | 23.5% – 25.5% | New |
| Dec 3, 2025 | adjusted free cash flow conversion | FY2026 | 85% – 95% | Raised |
| Dec 3, 2025 | Interest expense | FY2026 | $24.00M | Raised |
| Dec 3, 2025 | other income | FY2026 | $14.00M – $18.00M | Lowered |
| Dec 3, 2025 | Sales | FY2026 | +1% – +5% | Reaffirmed |
| Aug 26, 2025 | Capital expenditures | FY2026 | $65.00M – $85.00M | New |
| Aug 26, 2025 | EPS | FY2026 | $3.92 – $4.08 | New |
| Aug 26, 2025 | Operating margin | FY2026 | 16.1% – 16.7% | New |
| Aug 26, 2025 | effective income tax rate | FY2026 | 23.5% – 25.5% | New |
| Aug 26, 2025 | free cash flow conversion | FY2026 | 85% – 95% | Raised |
| Aug 26, 2025 | repurchase ... shares outstanding | FY2026 | 2% – 3% | Lowered |
| Aug 26, 2025 | Industrial sales | FY2026 | +2% – +6% | New |
| Aug 26, 2025 | Life Sciences sales | FY2026 | +1% – +5% | Lowered |
| Aug 26, 2025 | Interest expense | FY2026 | $22.00M – $23.00M | New |
| Aug 26, 2025 | other income | FY2026 | $14.00M – $18.00M | Lowered |
| Aug 26, 2025 | Sales | FY2026 | +1% – +5% | New |
| Jun 2, 2025 | Capital expenditures | FY2025 | $75.00M – $90.00M | New |
| Jun 2, 2025 | Adjusted full-year EPS | FY2025 | $3.64 – $3.70 | New |
| Jun 2, 2025 | adjusted free cash flow conversion | FY2025 | 80% – 90% | New |
| Jun 2, 2025 | Adjusted 2025 operating margin | FY2025 | 15.6% – 16% | New |
| Jun 2, 2025 | adjusted effective income tax rate | FY2025 | 23% – 24% | New |
| Jun 2, 2025 | Interest expense | FY2025 | $23.00M | New |
| Jun 2, 2025 | other income | FY2025 | $18.00M – $20.00M | Lowered |
| Jun 2, 2025 | Sales | FY2025 | +1% – +3% | New |
| Feb 26, 2025 | Capital expenditures | FY2025 | $85.00M – $100.00M | Lowered |
| Feb 26, 2025 | Adjusted full-year EPS | FY2025 | $3.60 – $3.68 | Narrowed |
| Feb 26, 2025 | Adjusted operating margin | FY2025 | 15.6% – 16% | Raised |
| Feb 26, 2025 | free cash flow conversion | FY2025 | 85% – 95% | Raised |
| Feb 26, 2025 | effective income tax rate | FY2025 | 23% – 25% | Lowered |
| Feb 26, 2025 | repurchasing shares outstanding | FY2025 | 2% – 3% | Lowered |
| Feb 26, 2025 | Mobile sales | FY2025 | -1% – +3% | New |
| Feb 26, 2025 | Industrial sales | FY2025 | +1% – +5% | Raised |
| Feb 26, 2025 | Interest expense | FY2025 | $21.00M | Raised |
| Feb 26, 2025 | other income | FY2025 | $18.00M – $20.00M | Lowered |
| Dec 2, 2024 | Capital expenditures | FY2025 | $85.00M – $105.00M | Reaffirmed |
| Dec 2, 2024 | Adjusted full-year EPS | FY2025 | $3.56 – $3.72 | Reaffirmed |
| Dec 2, 2024 | Adjusted operating margin | FY2025 | 15.3% – 15.9% | New |
| Dec 2, 2024 | Sales | FY2025 | +2% – +6% | Reaffirmed |
| Aug 27, 2024 | Capital expenditures | FY2025 | $85.00M – $105.00M | New |
| Aug 27, 2024 | Adjusted full-year EPS | FY2025 | $3.56 – $3.72 | New |
| Aug 27, 2024 | free cash flow conversion | FY2025 | 85% – 95% | New |
| Aug 27, 2024 | Operating margin | FY2025 | 15.3% – 15.9% | New |
| Aug 27, 2024 | Total operating margin | FY2026 | 15.8% – 16.6% | New |
| Aug 27, 2024 | effective income tax rate | FY2025 | 23% – 25% | New |
| Aug 27, 2024 | repurchase | FY2025 | 2% – 3% | Lowered |
| Aug 27, 2024 | Interest expense | FY2025 | $21.00M | New |
| Aug 27, 2024 | other income | FY2025 | $16.00M – $20.00M | Lowered |
| Aug 27, 2024 | Sales | FY2025 | +2% – +6% | New |
| Aug 27, 2024 | Total Company sales | FY2026 | +3% – +7% | New |
| Jun 3, 2024 | Capital expenditures | FY2024 | $90.00M – $105.00M | Lowered |
| Jun 3, 2024 | Full-year EPS | FY2024 | $3.33 – $3.39 | Raised |
| Jun 3, 2024 | free cash flow conversion | FY2024 | 95% – 105% | Reaffirmed |
| Jun 3, 2024 | Operating margin | FY2024 | 15% – 15.4% | New |
| Jun 3, 2024 | effective income tax rate | FY2024 | 23% – 24% | Raised |
| Jun 3, 2024 | repurchasing approximately 2% of its shares outstanding | FY2024 | 2% | Lowered |
| Jun 3, 2024 | Interest expense | FY2024 | $22.00M | Raised |
| Jun 3, 2024 | other income | FY2024 | $15.00M – $17.00M | Lowered |
| Jun 3, 2024 | Sales | FY2024 | +4% – +6% | Narrowed |
| Jun 3, 2024 | Mobile sales | FY2024 | +2% – +4% | Lowered |
| Jun 3, 2024 | Industrial sales | FY2024 | +6% – +8% | Raised |
| Feb 27, 2024 | Capital expenditures | FY2024 | $95.00M – $110.00M | Lowered |
| Feb 27, 2024 | Full-year EPS | FY2024 | $3.24 – $3.32 | Raised |
| Feb 27, 2024 | free cash flow conversion | FY2024 | 95% – 105% | New |
| Feb 27, 2024 | Operating margin | FY2024 | 15% – 15.4% | Raised |
| Feb 27, 2024 | Sales | FY2024 | +3% – +7% | Reaffirmed |
| Nov 28, 2023 | Capital expenditures | FY2024 | $95.00M – $115.00M | Reaffirmed |
| Nov 28, 2023 | full-year EPS | FY2024 | $3.14 – $3.30 | Reaffirmed |
| Nov 28, 2023 | Operating margin | FY2024 | 14.7% – 15.3% | Reaffirmed |
| Nov 28, 2023 | Sales | FY2024 | +3% – +7% | Reaffirmed |
| Aug 28, 2023 | Capital expenditures | FY2024 | $95.00M – $115.00M | New |
| Aug 28, 2023 | Full-year EPS | FY2024 | $3.14 – $3.30 | New |
| Aug 28, 2023 | free cash flow conversion | FY2024 | 95% – 105% | New |
| Aug 28, 2023 | Operating margin | FY2024 | 14.7% – 15.3% | New |
| Aug 28, 2023 | effective income tax rate | FY2024 | 24% – 26% | New |
| Aug 28, 2023 | repurchase of shares outstanding | FY2024 | 2% | Lowered |
| Aug 28, 2023 | Interest expense | FY2024 | $25.00M | New |
| Aug 28, 2023 | other income | FY2024 | $7.00M – $11.00M | Lowered |
| Aug 28, 2023 | Sales | FY2024 | +3% – +7% | New |
| May 30, 2023 | capital expenditures | FY2023 | $115.00M – $130.00M | Reaffirmed |
| May 30, 2023 | Adjusted EPS | FY2023 | $3.00 – $3.06 | Narrowed |
| May 30, 2023 | GAAP EPS | FY2023 | $2.90 – $2.96 | Narrowed |
| May 30, 2023 | free cash flow conversion | FY2023 | 105% – 115% | Lowered |
| May 30, 2023 | GAAP operating margin | FY2023 | 13.9% – 14.3% | Lowered |
| May 30, 2023 | adjusted operating margin | FY2023 | 14.4% – 14.8% | Lowered |
| May 30, 2023 | Sales | FY2023 | +3% – +5% | Narrowed |
| Feb 28, 2023 | capital expenditures | FY2023 | $115.00M – $130.00M | Lowered |
| Feb 28, 2023 | Adjusted EPS | FY2023 | $2.99 – $3.07 | Raised |
| Feb 28, 2023 | GAAP EPS | FY2023 | $2.89 – $2.97 | Narrowed |
| Feb 28, 2023 | GAAP operating margin | FY2023 | 14.1% – 14.5% | Lowered |
| Feb 28, 2023 | adjusted operating margin | FY2023 | 14.6% – 15% | Narrowed |
| Feb 28, 2023 | Sales | FY2023 | +2% – +6% | Raised |
| Nov 29, 2022 | capital expenditures | FY2023 | $115.00M – $135.00M | Reaffirmed |
| Nov 29, 2022 | Adjusted EPS | FY2023 | $2.91 – $3.07 | New |
| Nov 29, 2022 | GAAP EPS | FY2023 | $2.86 – $3.02 | New |
| Nov 29, 2022 | free cash flow conversion | FY2023 | 110% – 125% | New |
| Nov 29, 2022 | GAAP operating margin | FY2023 | 14.3% – 14.9% | New |
| Nov 29, 2022 | adjusted operating margin | FY2023 | 14.5% – 15.1% | New |
| Nov 29, 2022 | Sales | FY2023 | +1% – +5% | Reaffirmed |
| Aug 30, 2022 | capital expenditures | FY2023 | $115.00M – $135.00M | New |
| Aug 30, 2022 | EPS | FY2023 | $2.91 – $3.07 | New |
| Aug 30, 2022 | operating margin | FY2023 | 14.5% – 15.1% | New |
| Aug 30, 2022 | net sales | FY2023 | +1% – +5% | New |
| May 31, 2022 | capital expenditures | FY2022 | $90.00M – $100.00M | Lowered |
| May 31, 2022 | generally accepted accounting principles (GAAP) EPS | FY2022 | $2.67 – $2.73 | Narrowed |
| May 31, 2022 | Free cash flow conversion | FY2022 | 50% – 60% | Lowered |
| May 31, 2022 | gross margin | FY2022 | 1.5% – 2% | New |
| May 31, 2022 | operating margin | FY2022 | 13.5% – 13.9% | Lowered |
| May 31, 2022 | sales | FY2022 | +14.5% – +16.5% | Raised |
| Mar 1, 2022 | capital expenditures | FY2022 | $90.00M – $110.00M | Reaffirmed |
| Mar 1, 2022 | GAAP EPS | FY2022 | $2.66 – $2.76 | Raised |
| Mar 1, 2022 | free cash flow conversion | FY2022 | 70% – 80% | Reaffirmed |
| Mar 1, 2022 | operating margin | FY2022 | 14% – 14.4% | Lowered |
| Mar 1, 2022 | Net sales | FY2022 | +11% – +15% | Raised |
| Nov 30, 2021 | capital expenditures | FY2022 | $90.00M – $110.00M | New |
| Nov 30, 2021 | GAAP EPS | FY2022 | $2.57 – $2.73 | New |
| Nov 30, 2021 | Free cash flow conversion | FY2022 | 70% – 80% | New |
| Nov 30, 2021 | operating margin | FY2022 | 14.1% – 14.7% | New |
| Nov 30, 2021 | effective income tax rate | FY2022 | 24% – 26% | New |
| Nov 30, 2021 | repurchase approximately 2% of its outstanding shares | FY2022 | 2% | Lowered |
| Nov 30, 2021 | Engine sales | FY2022 | +8% – +12% | New |
| Nov 30, 2021 | Industrial sales | FY2022 | +7% – +11% | Lowered |
| Nov 30, 2021 | interest expense | FY2022 | $14.00M | New |
| Nov 30, 2021 | other income | FY2022 | $7.00M – $11.00M | Lowered |
| Nov 30, 2021 | Net sales | FY2022 | +8% – +12% | New |
Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.
Press releases
Releases Donaldson filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Update
- Update
- Results
- Results
- Results
- Results
- Results
- Results
- Results
- Update
- Results
- Results